Skip to main content
Clinical Trials/NL-OMON38914
NL-OMON38914
Recruiting
Not Applicable

eoGuard: A neonatal EEG monitor with real-time, bedside data visualization and automated decision support. - NeoGuard studie

Z Gasthuisberg Leuven0 sites65 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
asphyxia = Oxygen depletion during birth and seizures= fits
Sponsor
Z Gasthuisberg Leuven
Enrollment
65
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Z Gasthuisberg Leuven

Eligibility Criteria

Inclusion Criteria

  • Term babies with an umbilical pH less than 7,1
  • APGAR score less than 6 at 5 minutes
  • Thompson score more than 4\.
  • Term babies with clinical diagnosis of neonatal seizures

Exclusion Criteria

  • postmenstrual age less than 36 weeks, or postmenstrual age more then 36 weeks and at least one of the other criteria not fulfilled

Outcomes

Primary Outcomes

Not specified

Similar Trials